Shuffle Master, Navidea shares drop after hours

The gambling-equipment maker’s quarterly results miss Wall Street’s expectations, while a “disappointing” notification from U.S. drug regulator prompts a selloff in shares of Navidea Biopharma.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.